Logo wahanariau.com
  2. Crinetics pharmaceuticals

Crinetics pharmaceuticals

Index
Globenewswire

Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Jumat, 23 Januari 2026 - 20:31:02 Wib
Globenewswire

Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Jumat, 12 Desember 2025 - 17:50:57 Wib
Globenewswire

Crinetics Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRN09682 for the Treatment of Neuroendocrine Tumors and Other Somatostatin Receptor 2-Expressing Tumors

Jumat, 05 Desember 2025 - 05:09:37 Wib
Globenewswire

Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly

Sabtu, 27 September 2025 - 02:47:30 Wib